CCR5-Δ32 and IFNL4-ΔG/TT

被引：0
|
作者：
Jiang, Joy J. [1 ]
Fang, Michelle Z. [1 ]
Jackson, Sarah S. [1 ]
O'Brien, Thomas R. [1 ]
机构：
[1] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
来源：
CLINICAL THERAPEUTICS | 2019年 / 41卷 / 12期
基金：
美国国家卫生研究院;
关键词：
IFNL4;
D O I：
10.1016/j.clinthera.2019.10.004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2658 / 2659
页数：2
相关论文
共 50 条
  • [41] Distribution of CCR5-Δ32 and CCR2-64I alleles in an argentine Amerindian population
    Mangano, A
    Theiler, G
    Sala, L
    Capucchio, M
    Fainboim, L
    Sen, L
    TISSUE ANTIGENS, 2001, 58 (02): : 99 - 102
  • [42] HIV-1 protecting CCR5-Δ32 allele in medieval Poland
    Zawicki, Przemyslaw
    Witas, Henryk W.
    INFECTION GENETICS AND EVOLUTION, 2008, 8 (02) : 146 - 151
  • [43] Detection of the CCR5-Δ32 HIV resistance gene in Bronze Age skeletons
    Hummel, S
    Schmidt, D
    Kremeyer, B
    Herrmann, B
    Oppermann, M
    GENES AND IMMUNITY, 2005, 6 (04) : 371 - 374
  • [44] Detection of the CCR5-Δ32 HIV resistance gene in Bronze Age skeletons
    S Hummel
    D Schmidt
    B Kremeyer
    B Herrmann
    M Oppermann
    Genes & Immunity, 2005, 6 : 371 - 374
  • [45] The prevalence of CCR5-Δ32 mutation in a cohort of Saudi stem cell donors
    Alarifi, M.
    Al-Amro, F.
    Alalwan, A.
    Al-Turki, A.
    Fakhoury, H.
    Atallah, N.
    Al-Muallimi, M.
    Al-Balwi, M.
    Alzahrani, M.
    Alaskar, A.
    Hajeer, A.
    Jawdat, D.
    HLA, 2017, 90 (05) : 292 - 294
  • [46] IFNL4-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections
    Minas, Tsion Zewdu
    Tang, Wei
    Smith, Cheryl J.
    Onabajo, Olusegun O.
    Obajemu, Adeola
    Dorsey, Tiffany H.
    Jordan, Symone, V
    Obadi, Obadi M.
    Ryan, Brid M.
    Prokunina-Olsson, Ludmila
    Loffredo, Christopher A.
    Ambs, Stefan
    COMMUNICATIONS BIOLOGY, 2018, 1
  • [47] Combined effect of CCR5-Δ32 heterozygosity and the CCR5 promoter polymorphism-2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission
    Hladik, F
    Liu, HL
    Speelmon, E
    Livingston-Rosanoff, D
    Wilson, S
    Sakchalathorn, P
    Hwangbo, Y
    Greene, B
    Zhu, TF
    McElrath, MJ
    JOURNAL OF VIROLOGY, 2005, 79 (18) : 11677 - 11684
  • [48] Analysis of the involvement of CCR5-Δ32 and CCR2-V64I variants in the development of endometriosis
    Antiñolo, G
    Fernández, RM
    Noval, JA
    Moliní, JL
    Borrego, S
    MOLECULAR HUMAN REPRODUCTION, 2004, 10 (03) : 155 - 157
  • [49] CCR5-Δ32 does not affect HCV-specific immune responses.
    Ahlenstiel, G
    Iwan, A
    Nattermann, J
    Rockstroh, JK
    Brackmann, HH
    Kupfer, B
    Sauerbruch, T
    Spengler, U
    Woitas, RP
    HEPATOLOGY, 2004, 40 (04) : 447A - 447A
  • [50] Investigation of the frequency of the mutant CCR5-Δ32 allele related to HIV resistance in Turkey
    Karakaya, Gamze
    Budak Yildiran, Fatma Azize
    Cakir Arica, Sukran
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2013, 43 (06) : 886 - 890
12345